ALBERTON, FRANCESCA
ALBERTON, FRANCESCA
Facoltà di Medicina e Chirurgia
Antibiotic resistance among sexually transmitted infections: perspectives from clinical practice
2022-01-01 Raccagni, A. R.; Bruzzesi, E.; Cernuschi, M.; Galli, L.; Alberton, F.; Mancini, N.; Castagna, A.; Nozza, S.
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort
2022-01-01 Nozza, S.; Raccagni, A. R.; Lolatto, R.; Ceccarelli, D.; Galli, L.; Alberton, F.; Bruzzesi, E.; Canetti, D.; Strano, M.; Ripa, M.; Bertoni, C.; Castagna, A.
HIV viral load monitoring during monkeypox virus infection among people with HIV
2023-01-01 Raccagni, A. R.; Mileto, D.; Galli, L.; Bruzzesi, E.; Canetti, D.; Rizzo, A.; Bertoni, C.; Clemente, T.; Alberton, F.; Castagna, A.; Nozza, S.
Outcome of Darunavir–Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological Failure
2024-01-01 Alberton, F.; Galli, L.; Lolatto, R.; Candela, C.; Gianotti, N.; Chiurlo, M.; Ranzenigo, M.; Strano, M.; Uglietti, A.; Castagna, A.
Sexually Transmitted Enteric Infections in Men Who Have Sex With Men Living With HIV Over 8 Years of Follow-up
2022-01-01 Raccagni, A. R.; Bruzzesi, E.; Alberton, F.; Ceccarelli, D.; Lolatto, R.; Canetti, D.; Castagna, A.; Nozza, S.
The propensity for long-acting cabotegravir and rilpivirine every 2 months among HIV-infected people eligible for treatment
2023-01-01 Alberton, F.; Nozza, S.; Raccagni, A. R.; Galli, L.; Spagnuolo, V.; Bossolasco, S.; Cernuschi, M.; Canetti, D.; Hasson, H.; Castagna, A.; Gianotti, N.
Vaccines against Emerging Sexually Transmitted Infections: Current Preventive Tools and Future Perspectives
2022-01-01 Raccagni, Ar; Alberton, F; Castagna, A; Nozza, S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Antibiotic resistance among sexually transmitted infections: perspectives from clinical practice | 1-gen-2022 | Raccagni, A. R.; Bruzzesi, E.; Cernuschi, M.; Galli, L.; Alberton, F.; Mancini, N.; Castagna, A.; Nozza, S. | |
| Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort | 1-gen-2022 | Nozza, S.; Raccagni, A. R.; Lolatto, R.; Ceccarelli, D.; Galli, L.; Alberton, F.; Bruzzesi, E.; Canetti, D.; Strano, M.; Ripa, M.; Bertoni, C.; Castagna, A. | |
| HIV viral load monitoring during monkeypox virus infection among people with HIV | 1-gen-2023 | Raccagni, A. R.; Mileto, D.; Galli, L.; Bruzzesi, E.; Canetti, D.; Rizzo, A.; Bertoni, C.; Clemente, T.; Alberton, F.; Castagna, A.; Nozza, S. | |
| Outcome of Darunavir–Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological Failure | 1-gen-2024 | Alberton, F.; Galli, L.; Lolatto, R.; Candela, C.; Gianotti, N.; Chiurlo, M.; Ranzenigo, M.; Strano, M.; Uglietti, A.; Castagna, A. | |
| Sexually Transmitted Enteric Infections in Men Who Have Sex With Men Living With HIV Over 8 Years of Follow-up | 1-gen-2022 | Raccagni, A. R.; Bruzzesi, E.; Alberton, F.; Ceccarelli, D.; Lolatto, R.; Canetti, D.; Castagna, A.; Nozza, S. | |
| The propensity for long-acting cabotegravir and rilpivirine every 2 months among HIV-infected people eligible for treatment | 1-gen-2023 | Alberton, F.; Nozza, S.; Raccagni, A. R.; Galli, L.; Spagnuolo, V.; Bossolasco, S.; Cernuschi, M.; Canetti, D.; Hasson, H.; Castagna, A.; Gianotti, N. | |
| Vaccines against Emerging Sexually Transmitted Infections: Current Preventive Tools and Future Perspectives | 1-gen-2022 | Raccagni, Ar; Alberton, F; Castagna, A; Nozza, S |